Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vernarbende Alopezien.

Varvara Kanti1, Joachim Röwert-Huber1, Annika Vogt1

  • 1Klinik für Dermatologie, Venerologie und Allergologie, Charité - Universitätsmedizin Berlin.

Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|April 13, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The follicular microbiome in hair-follicle-associated inflammatory diseases: A systematic review.

Clinical and experimental dermatology·2026
Same author

Hair Loss in Patients on Glucagon-Like Peptide 1 Receptor Agonists: Understanding Risks and Managing Outcomes.

Dermatology and therapy·2026
Same author

Skin and Wound Infection Models to Test Host-Pathogen Interactions and Evaluate Topical Antimicrobial Treatments.

Methods in molecular biology (Clifton, N.J.)·2026
Same author

S3 guideline diagnostics and therapy in alopecia areata - Part 2: Therapy, psychosocial and cosmetic support.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same author

Genome-wide association study of atopic and autoimmune comorbidities in alopecia areata.

Frontiers in immunology·2026
Same author

Rhesus blood group haplotype determination by nanopore sequencing and adaptive sampling enables the precise determination of complex allele combinations that could not be accurately determined by standard methods.

Transfusion·2026
Same journal

The different face of skin-rash induced by brentuximab vedotin.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Repositioning Non-Ablative Fractional Lasers - Molecular and Histological Insights from a scoping review.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Infusion-site reactions to foslevodopa/foscarbidopa in Parkinson's disease.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Tranexamic Acid-Soaked Intranasal Packing for Postoperative Bleeding After Nasal Interpolation Flap Repair.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Monoclonal gammopathy of dermatological significance: non-amyloid paraprotein deposits with light and heavy chains.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Same journal

Papular epidermal nevus with "skyline" basal cell layer: Clinical clues from a three-member family.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
See all related articles

Primär vernarbende Alopezien (PVA) are hair loss conditions classified by inflammation type. Early diagnosis and tailored treatments, including anti-inflammatory therapies, are crucial for managing PVA and preventing further scarring.

Area of Science:

  • Dermatology
  • Trichology

Background:

  • Primär vernarbende Alopezien (PVA) are classified into four groups based on inflammatory infiltrate: lymphocytic, neutrophilic, mixed, or nonspecific.
  • PVA onset is often insidious, leading to delayed diagnosis, especially in early or late stages.

Purpose of the Study:

  • To outline diagnostic approaches for PVA, including history, examination, trichoscopy, and biopsy when necessary.
  • To review therapeutic goals for PVA, focusing on halting hair loss, reducing inflammation, preventing scarring, and alleviating symptoms.

Main Methods:

  • Comprehensive patient history and full-body dermatological examination.
  • Trichoscopy for clinical assessment.
  • Biopsy for histopathological diagnosis in unclear cases.

Related Experiment Videos

Main Results:

  • Topical corticosteroids (class III-IV) and intralesional triamcinolone acetonide injections are common anti-inflammatory treatments.
  • Systemic therapy choice depends on the predominant inflammatory infiltrate, utilizing antimicrobial or immunomodulatory/immunosuppressive agents.

Conclusions:

  • Treatment aims to slow hair loss and inflammation, not hair regrowth in scarred areas.
  • Psychological support and camouflage techniques are important adjuncts for patients with PVA.